Vaccines

In this eBook, experts give their views on enhancing downstream purification.

We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.

Vaccine development for COVID-19 may have been rapid, but no one has scrimped on safety.

The creators of the COVID-19 Curator give their perspectives on the pandemic and how it has changed their day-to-day lives.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

As part of the CPhI Festival of Pharma 2020, we brought together experts from our annual Power List to discuss the impact of COVID-19 on the industry.

Will the rapid development of COVID-19 vaccines lead to unsafe therapies?

The COVID-19 vaccines demonstrate what’s possible when disease is tackled as a genuine priority.

What have we learned from the pandemics of the past? Experts give their view in a video discussion.

What have we learned from the pandemic and how can we address the coming challenges?